APA (7th ed.) Citation

Agarwal, R., Hauske, S. J., Wheeler, D. C., Doi, K., Elsaesser, A., Ritter, I., . . . Wanner, C. (2022). Empagliflozin and incidence of events consistent with acute kidney injury: Pooled safety analysis in more than 15 000 individuals : research letter. Diabetes, obesity and metabolism, 24(7), . https://doi.org/10.1111/dom.14694

Chicago Style (17th ed.) Citation

Agarwal, Rajiv, Sibylle J. Hauske, David C. Wheeler, Kent Doi, Amelie Elsaesser, Ivana Ritter, Dominik Steubl, and Christoph Wanner. "Empagliflozin and Incidence of Events Consistent with Acute Kidney Injury: Pooled Safety Analysis in More than 15 000 Individuals : Research Letter." Diabetes, Obesity and Metabolism 24, no. 7 (2022). https://doi.org/10.1111/dom.14694.

MLA (9th ed.) Citation

Agarwal, Rajiv, et al. "Empagliflozin and Incidence of Events Consistent with Acute Kidney Injury: Pooled Safety Analysis in More than 15 000 Individuals : Research Letter." Diabetes, Obesity and Metabolism, vol. 24, no. 7, 2022, https://doi.org/10.1111/dom.14694.